Core Insights - Infortar reported a significant increase in sales revenue and EBITDA for the year 2025, with sales revenue rising by over one third to EUR 1.837 billion and EBITDA increasing by 60% to EUR 233 million [1][11][12]. Financial Performance - The Group's total assets reached EUR 2.588 billion, with equity amounting to EUR 1.178 billion and net profit of EUR 72 million [1][15]. - Loan liabilities decreased by one sixth to EUR 1.060 billion, while net debt declined by one fifth to EUR 841 million [1][16]. - The consolidated net profit for 2025 was EUR 71.969 million, down from EUR 193.670 million in 2024, but underlying profitability improved when excluding one-off gains from the previous year [15][23]. Business Segments - The maritime transport segment faced challenges, with Tallink carrying 1.3 million passengers, a decrease of 0.3% year-over-year [6]. - The energy segment, represented by Elenger Grupp, sold 4.8 TWh of energy in Q4 2025, with a market share of 21% [7]. - The real estate segment continued construction projects, including a EUR 67.2 million contract for Rail Baltica and a commercial space for Depo [8]. Investment Strategy - Infortar's investments in agriculture, including the acquisition of Estonian dairy farms, are seen as a strategic move to balance the portfolio and support long-term growth [5]. - The company aims to diversify its risk and generate stable cash flows through active portfolio management across different sectors [4]. Dividends - The Management Board intends to propose a dividend of EUR 3.02 per share for the 2025 financial year, which includes a base dividend and additional dividends from Tallink [17].

Wolters Kluwer 2025 Full-Year Report Alphen aan den Rijn, February 25, 2026 – Wolters Kluwer, a global leader in professional information solutions, software and services, today releases its full-year 2025 results. Highlights Revenues €6,125 million, up 7% in constant currencies and up 6% organically. Recurring revenues (83% of total revenues) up 7% organically; non-recurring down 1%.Cloud software revenues (21% of total revenues) up 15% organically.Print reduced organic growth by 50 basis points. Adjusted ...

Acquisition includes HS235, a potentially best-in-class activin signalling inhibitor in clinical development for treatment of cardiopulmonary diseasesHS235 offers potential to treat pulmonary hypertension (PH) patients while reducing the risk of bleeding and providing unique metabolic benefits compared to existing therapies MONTREAL, Feb. 25, 2026 (GLOBE NEWSWIRE) -- 35Pharma, a Canada-based, private, clinical-stage biopharmaceutical company specialised in the development of novel protein-based therapeutics ...

AB “Ignitis grupė“ (hereinafter – the Group) informs that on 24 February 2026, as part of its asset rotation program and in order to ensure proper implementation of the decision of the European Commission (hereinafter – the EC), it has agreed with Quaero European Infrastructure Fund III, a fund managed by Quaero Capital SA (hereinafter – Quaero Capital), on the sale of a 49% stake in UAB Vilniaus kogeneracinė jėgainė (hereinafter – Vilnius CHP) managed by the Group. This is one of the largest foreign direct ...

Nanterre, 25 February 2026 VINCI launches an issue of bonds exchangeable for existing ordinary shares of Groupe ADP due 2031 for a nominal amount of €500m VINCI (the “Issuer”), owning 8.0% of Groupe ADP’s share capital, announces its intention to issue a bond exchangeable for Groupe ADP shares (the “Shares”). VINCI has decided to issue a €500 million bond exchangeable into Shares (the “Bonds” and together with the Shares, the “Securities”) as a competitive funding source, allowing to potentially monetize a ...

Core Insights - Novonesis achieved strong organic sales growth of 7% in 2025, with an adjusted EBITDA margin of 37.1% and robust cash flow despite currency challenges [1][4] - The company anticipates a positive start to 2026, projecting continued growth across all sales areas and margin expansion [1][4] Financial Performance - Organic sales growth was broad-based, with Food & Health segment growing at 8% and Planetary Health at 6% [4] - Emerging Markets saw a 9% organic growth, while Developed Markets grew by 6% [4] - Adjusted net profit increased by 17%, and free cash flow before acquisitions was EUR 770.4 million, representing 19% of sales [4] - Proposed dividend of DKK 4.25 per share, with a payout ratio of 58.4% of adjusted net profit for 2025 [4] Strategic Developments - The company launched 33 new products in 2025, with innovations from the last five years accounting for 25% of sales [4] - Novonesis achieved all six environmental and social targets for 2025 and is on track for future commitments [4] 2026 Outlook - The company expects organic sales growth between 5-7% for 2026, with some uncertainty regarding consumer sentiment [4] - The outlook includes approximately 1%-point contribution from positive pricing and sales synergies, alongside a near 1%-point negative impact from exiting certain countries [4] - Adjusted EBITDA margin is projected to be between 37-38%, with expected margin expansion despite currency headwinds [4]

Group 1: Outlook for 2026 - AL Sydbank projects moderate growth in the Danish economy for 2026, with profit after tax expected to be in the range of DKK 3,500-4,000 million, assuming the Danish central bank maintains the certificate of deposit rate [1] Group 2: Share Buyback Program - The Board of Directors has approved a share buyback program amounting to DKK 1,100 million, aimed at reducing the Bank's share capital [2] - The share buyback program will commence on March 2, 2026, and is scheduled to be completed by January 31, 2027 [3] - Danske Bank A/S has been selected to manage the share buyback program, which will adhere to the Safe Harbour rules as per EU regulations [4] Group 3: Purchase Guidelines - Shares will not be purchased at a price exceeding the higher of the last independent trade price or the highest current independent purchase bid on the trading venue [5] - Daily purchases will be limited to 25% of the average daily volume of shares traded in the preceding 20 trading days [5] - AL Sydbank will disclose the number and value of repurchased shares every week on the first banking day [5] Group 4: Program Flexibility - AL Sydbank reserves the right to suspend or terminate the share buyback program at any time, with such decisions to be announced publicly [6]

Group 1 - The Annual General Meeting of AL Sydbank A/S is scheduled for Thursday, March 19, 2026, at 3:00 PM [1] - The notice and agenda for the general meeting have been attached to the announcement [1]

Core Viewpoint - Worldline is selling its Indian payment activities to BillDesk for an estimated equity value of approximately €60 million, while entering a long-term technology partnership to ensure operational continuity and leverage Worldline's advanced payment software [2][3]. Group 1: Transaction Details - The enterprise value of the transaction is approximately €37 million, with an estimated equity value at closing of around €60 million [5]. - The revenue, Adjusted EBITDA, and free cash flow deconsolidation impact from this transaction are estimated at approximately €90 million, €8 million, and free cash flow neutral on a full-year basis, respectively [5]. - The transaction is expected to close in the second half of 2026, subject to customary processes and applicable laws [7]. Group 2: Strategic Implications - This sale is a significant step in Worldline's strategy to focus on core payment activities in Europe, streamline operations, and optimize resource allocation [6]. - The estimated cash proceeds from this transaction will enhance Worldline's financial profile and strategic flexibility, allowing for capital redeployment towards core activities [6]. Group 3: Commitment to India - Worldline remains committed to India as a strategic hub for talent and innovation, planning to evolve its Global Competence Centres into innovation hubs to build critical payment talent pools and drive automation and AI at scale [4].

Core Insights - Ageas reported strong financial results for the full year 2025, highlighting a transformational year for the company [1][2] - The company achieved a 9% increase in inflows, with a notable 33% rise in net operating results, reaching EUR 1.65 billion [1][2] - Ageas proposed a gross cash dividend of EUR 3.75, reflecting its commitment to shareholders [1][2] Financial Performance - Total inflows reached EUR 19.6 billion, marking a 9% increase compared to 2024 [1] - The net operating result was EUR 1.65 billion, up 33% from the previous year [1] - Free cash flow amounted to EUR 774 million, representing a 19% increase year-over-year [1] - The proposed gross cash dividend for 2025 is EUR 3.75, a 7% increase from 2024 [1] Strategic Developments - The acquisition of esure positioned Ageas as the 3rd largest personal lines insurer in the UK, while full ownership of Belgium's leading insurer AG was secured [2] - The Elevate27 strategy gained momentum, allowing the company to raise financial targets twice during the year [2] - Key strategic initiatives included a focus on ageing, SMEs, and enhanced use of Data & AI [2] Sustainability and ESG Performance - Ageas made significant progress in sustainability, earning positive recognition from employees and customers [2] - The company ranks in the top quartile with three of the five ESG rating agencies it engages with [2] - The portfolio of sustainable products continued to grow, reflecting the trust of customers and employees [2]